MLSS
MILESTONE SCIENTIFIC INC.
+0.02 (+6.25%)0.43USD24.1K成交股數37.7M市值–本益比(近四季)4.0股價營收比+22.3%營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 2.8M+22% | 2.2M-3% | 2.1M-18% | 2.4M+27% | 2.3M+3% | 2.2M-1% | 2.5M+22% | 1.9M-36% | 2.2M | 2.3M | 2.1M | 2.9M |
| 營業成本 | 931K | 598K | 556K | 719K | 706K | 585K | 678K | 443K | 573K | 751K | 556K | 1.0M |
| 毛利 | 1.9M+18% | 1.6M-5% | 1.5M-18% | 1.6M+16% | 1.6M-3% | 1.6M+9% | 1.8M+22% | 1.4M-25% | 1.7M | 1.5M | 1.5M | 1.9M |
| 毛利率 | 67.2% | 72.3% | 73.0% | 69.5% | 69.6% | 73.8% | 73.0% | 76.1% | 74.5% | 66.8% | 73.0% | 65.0% |
| 研發費用 | 7K | – | 12K | 16K | 52K | 369K | 232K | 315K | 94K | 177K | 170K | 214K |
| 銷售管理費用 | 2.9M | 2.4M | 2.5M | 2.7M | 3.0M | 3.3M | 3.1M | 2.9M | 3.0M | 3.3M | 2.8M | 3.9M |
| 營業利益 | −1.1M-28% | −828K-59% | −1.1M-27% | −1.1M-36% | −1.5M+1% | −2.0M+1% | −1.5M-2% | −1.8M-22% | −1.5M | −2.0M | −1.5M | −2.3M |
| 營業利益率 | -37.4% | -38.3% | -52.5% | -48.1% | -63.9% | -89.5% | -58.4% | -96.0% | -65.1% | -87.6% | -73.2% | -78.3% |
| 稅後淨利 | −1.1M-29% | −840K-58% | 10.4M-809% | −1.2M-616% | −1.5M+3% | −2.0M-117% | −1.5M-0% | 224K-110% | −1.4M | 11.9M | −1.5M | −2.2M |
| 淨利率 | -37.3% | -38.8% | 503.1% | -48.9% | -63.8% | -89.3% | -58.1% | 12.1% | -64.1% | 527.3% | -71.2% | -76.2% |
| 稀釋 EPS | -0.01-50% | -0.01-50% | -0.020% | -0.01 | -0.02 | -0.02 | -0.02 | – | – | – | – | – |
| 稀釋股數 | 93.1M | 85.0M | 82.1M | 82.3M | 82.0M | 81.9M | 80.0M | 80.0M | – | – | – | 72.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | – | 1.2M | 1.1M | 1.3M | 1.3M | 2.2M | 4.8M | 5.8M | 4.0M | 3.0M | 2.2M | 3.7M |
| 應收帳款 | – | – | – | – | – | – | 551K | 387K | 662K | 313K | 591K | 790K |
| 存貨 | 3.1M | 3.5M | 3.8M | 4.1M | 3.9M | 4.2M | 3.7M | 3.3M | 2.9M | 2.6M | 2.5M | 2.2M |
| 總資產 | 8.3M | 8.0M | 7.8M | 8.5M | 8.1M | 9.1M | 11.2M | 12.0M | 11.4M | 11.4M | 11.4M | 11.4M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 4.9M | 5.7M | 5.0M | 5.9M | 4.7M | 4.6M | 4.0M | 4.1M | 3.9M | 3.4M | 3.6M | 3.4M |
| 股東權益 | 3.5M | 2.3M | 2.8M | 2.5M | 3.3M | 4.5M | 7.2M | 8.0M | 7.5M | 8.0M | 7.2M | 7.9M |
| 負債比 | 58.4% | 71.3% | 64.0% | 70.0% | 58.5% | 50.9% | 35.4% | 33.7% | 34.3% | 29.5% | 31.6% | 30.3% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 87K-109% | – | – | – | −1.0M | – | – | −1.2M | – | – | – |
| 資本支出 | – | 2K | – | – | – | 1K | – | – | – | – | – | – |
| 自由現金流 | – | 85K-108% | – | – | – | −1.0M | – | – | – | – | – | – |
| 折舊攤銷 | 20K | 19K | 19K | 20K | 19K | 19K | 9K | 8K | 12K | 12K | 16K | 17K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 3.9% | – | – | – | -45.2% | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 17.9M
| Dental | 8.8M | 49.0% | +3.1% |
|---|---|---|---|
| Dental | 8.8M | 49.0% | +3.1% |
| Medical | 183K | 1.0% | +75.2% |
| Medical | 183K | 1.0% | +75.2% |
地區2025 年度 · 9.0M
| 美國 | 5.0M | 55.4% | -5.4% |
|---|---|---|---|
| 其他地區 | 3.7M | 41.2% | +9.5% |
| 中國 | 310K | 3.5% | – |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 9.0M | +4.0% | 5.7M | 63.8% | -0.07 | −2.9M |
| FY2024 | 8.6M | -12.2% | 4.7M | 54.6% | -0.06 | −2.9M |
| FY2023 | 9.8M | +11.6% | 6.9M | 70.5% | – | – |
| FY2022 | 8.8M | -14.5% | −8.7M | -98.9% | – | −6.0M |
| FY2021 | 10.3M | +89.5% | −6.8M | -66.2% | -0.10 | −4.0M |
| FY2020 | 5.4M | -35.1% | −7.3M | -134.9% | -0.12 | −7.0M |
| FY2019 | 8.4M | -13.0% | −7.5M | -89.8% | -0.16 | −1.8M |
| FY2018 | 9.6M | – | −7.4M | -77.2% | -0.21 | −1.6M |